What is PATH?
Headquartered in Seattle, Washington, PATH operates as a nonprofit innovator focused on the intersection of technology and public health. The organization serves as a critical bridge between research, development, and community-level implementation, aiming to eliminate health disparities. By providing the necessary infrastructure and expertise to innovators, PATH facilitates the creation of sustainable health systems. Its market position is defined by a unique blend of philanthropic mission and rigorous, data-driven operational strategies, allowing it to tackle complex challenges in global health equity that traditional commercial entities might overlook.
How much funding has PATH raised?
PATH has raised a total of $100.2M across 6 funding rounds:
Angel/Seed
$2.5M
Series A
$10.8M
Series B
$30M
Series C
$24.9M
Unspecified
$7M
Other Financing Round
$25M
Angel/Seed (2010): $2.5M with participation from Founders Fund, SV Angel, First Round Capital, and Index Ventures
Series A (2011): $10.8M led by Kleiner Perkins Caufield & Byers, Index Ventures, Digital Garage, and First Round Capital
Series B (2012): $30M supported by Shasta Ventures, Kleiner Perkins Caufield & Byers, Index Ventures, Redpoint Ventures, Greylock Partners, and Allen & Company
Series C (2013): $24.9M featuring Greylock Partners, Index Ventures, Redpoint Venture Partners, First Round Capital, Insight Venture Partners, Kleiner Perkins Caufield & Byers, and Bakrie & Brothers
Unspecified (2013): $7M, investors not publicly disclosed
Other Financing Round (2017): $25M with participation from Clarus Ventures
Key Investors in PATH
Index Ventures
Index Ventures is a venture firm investing in the next generation of entrepreneurs from seed to IPO, partnering with founders who challenge the status quo.
Kleiner Perkins Caufield & Byers
Kleiner Perkins is a Menlo Park-based venture capital firm that invests in early and growth-stage technology and life-science companies.
First Round Capital
First Round Capital is a venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs to achieve significant results.
What's next for PATH?
Looking ahead, PATH is positioned to leverage its substantial capital reserves to deepen its impact in emerging markets and underserved populations. The strategic focus will likely shift toward scaling existing health technologies and expanding partnerships with both public and private sector stakeholders. As the organization continues to mature, the emphasis on sustainable, long-term health outcomes will remain the primary driver of its strategic roadmap. By maintaining its focus on high-impact innovation, PATH is well-equipped to navigate the evolving landscape of global health, ensuring that its resources are directed toward the most pressing needs in community wellness and medical accessibility.
See full PATH company page
